| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 107.863 | 129.905 | 125.096 | 79.560 | 87.417 | 103.677 | 92.951 | 68.465 | 90.692 | 87.084 |
| Total Income - EUR | 107.915 | 140.214 | 134.413 | 79.560 | 87.417 | 103.687 | 92.952 | 68.465 | 90.845 | 96.723 |
| Total Expenses - EUR | 106.389 | 133.898 | 108.398 | 85.252 | 84.045 | 98.064 | 87.170 | 65.745 | 83.304 | 90.449 |
| Gross Profit/Loss - EUR | 1.526 | 6.316 | 26.015 | -5.691 | 3.372 | 5.623 | 5.781 | 2.720 | 7.541 | 6.274 |
| Net Profit/Loss - EUR | 1.257 | 4.995 | 22.771 | -6.488 | 2.498 | 4.667 | 4.943 | 2.049 | 6.648 | 4.568 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Medicamex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 25.117 | 33.578 | 37.374 | 26.330 | 14.439 | 4.349 | 1.251 | 0 | 41.111 | 31.007 |
| Current Assets | 44.652 | 61.502 | 35.207 | 31.897 | 23.553 | 50.519 | 46.478 | 19.660 | 20.719 | 28.431 |
| Inventories | 35.187 | 42.665 | 28.767 | 25.620 | 17.465 | 31.718 | 11.743 | 7.033 | 3.207 | 5.663 |
| Receivables | 7.824 | 11.806 | 4.582 | 3.310 | 1.295 | 1.124 | 1.212 | 6.614 | 10.176 | 12.285 |
| Cash | 1.640 | 7.031 | 1.858 | 2.967 | 4.792 | 17.677 | 33.523 | 6.012 | 7.336 | 10.484 |
| Shareholders Funds | 8.872 | 13.777 | 31.404 | 24.340 | 26.366 | 30.534 | 34.799 | 12.409 | 14.977 | 15.091 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 60.944 | 81.350 | 41.177 | 33.887 | 11.626 | 24.335 | 12.930 | 7.250 | 46.274 | 44.136 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 579 | 212 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Medicamex Srl